Vise Technologies Inc. Boosts Holdings in McKesson Co. (NYSE:MCK)

Vise Technologies Inc. grew its position in shares of McKesson Co. (NYSE:MCK - Free Report) by 129.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,601 shares of the company's stock after purchasing an additional 904 shares during the quarter. Vise Technologies Inc.'s holdings in McKesson were worth $912,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Cibc World Market Inc. lifted its holdings in McKesson by 6.3% in the fourth quarter. Cibc World Market Inc. now owns 20,252 shares of the company's stock valued at $11,542,000 after buying an additional 1,207 shares during the period. Brentview Investment Management LLC acquired a new position in shares of McKesson in the 4th quarter valued at about $3,018,000. Ingalls & Snyder LLC lifted its stake in shares of McKesson by 8.2% in the 4th quarter. Ingalls & Snyder LLC now owns 13,824 shares of the company's stock valued at $7,878,000 after purchasing an additional 1,047 shares during the period. Chicago Partners Investment Group LLC boosted its position in shares of McKesson by 85.0% during the 4th quarter. Chicago Partners Investment Group LLC now owns 1,262 shares of the company's stock valued at $745,000 after purchasing an additional 580 shares in the last quarter. Finally, Blue Trust Inc. grew its stake in McKesson by 6.4% during the fourth quarter. Blue Trust Inc. now owns 7,830 shares of the company's stock worth $4,462,000 after purchasing an additional 468 shares during the period. Institutional investors and hedge funds own 85.07% of the company's stock.

McKesson Trading Up 0.0%

Shares of MCK traded up $0.14 on Thursday, reaching $712.27. The company's stock had a trading volume of 506,714 shares, compared to its average volume of 957,382. McKesson Co. has a twelve month low of $464.42 and a twelve month high of $731.00. The stock has a market capitalization of $89.11 billion, a PE ratio of 32.61, a PEG ratio of 1.29 and a beta of 0.53. The firm has a fifty day moving average of $693.02 and a 200-day moving average of $636.30.

McKesson (NYSE:MCK - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported $10.12 EPS for the quarter, topping the consensus estimate of $9.83 by $0.29. The firm had revenue of $90.82 billion during the quarter, compared to the consensus estimate of $94 billion. McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. The company's quarterly revenue was up 18.9% compared to the same quarter last year. During the same period in the prior year, the business posted $6.18 earnings per share. As a group, equities analysts anticipate that McKesson Co. will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, July 1st. Investors of record on Monday, June 2nd will be given a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.40%. The ex-dividend date is Monday, June 2nd. McKesson's payout ratio is currently 10.99%.

Insider Buying and Selling

In other McKesson news, EVP Leann B. Smith sold 341 shares of McKesson stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $717.91, for a total transaction of $244,807.31. Following the transaction, the executive vice president now owns 2,800 shares of the company's stock, valued at $2,010,148. This trade represents a 10.86% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Napoleon B. Rutledge, Jr. sold 543 shares of the business's stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $726.51, for a total value of $394,494.93. Following the completion of the transaction, the chief accounting officer now owns 1,972 shares in the company, valued at $1,432,677.72. The trade was a 21.59% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 10,856 shares of company stock worth $7,793,675. 0.11% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

MCK has been the topic of several recent analyst reports. Bank of America boosted their price target on McKesson from $755.00 to $800.00 and gave the company a "buy" rating in a research note on Friday, May 9th. Cfra Research downgraded shares of McKesson from a "moderate buy" rating to a "hold" rating in a research report on Friday, April 4th. Mizuho increased their target price on shares of McKesson from $630.00 to $690.00 and gave the stock a "neutral" rating in a research note on Thursday, April 3rd. UBS Group lifted their price target on shares of McKesson from $708.00 to $805.00 and gave the company a "buy" rating in a research note on Tuesday, April 29th. Finally, Wall Street Zen cut shares of McKesson from a "strong-buy" rating to a "buy" rating in a research report on Wednesday, May 21st. Three analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $686.69.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.